Europe Infection Control Market

Europe Infection Control Market Size (2023 to 2028)

The Europe infection control market is forecasted to grow at a CAGR of 11.54% during the forecast period. The market size is expected to be USD 25.34 billion by 2028 from USD 14.67 billion in 2023.

Increasing adoption of infection control methods in healthcare facilities across the European region is propelling the European infection control market. Healthcare-associated infections (HAI) are primarily seen in hospitals and may affect several patients in the hospital who are taking treatment. Some common hospital-acquired infections are ear infections, skin infections, common childhood infections, eye infections, lung and respiratory infections, and stomach and intestinal infections. To reduce this infection, infection control methods are used in operating rooms and hospital premises.

The growing incidence of chronic diseases and increasing number of surgical procedures in the European region are expected to boost the European infection control market growth. The incidence of chronic diseases such as cancer, CVDs, and neurovascular diseases can be seen more in aged people. Older people undergo surgeries that require infection control methods to avoid other complications caused by the surrounding contamination. In addition, the infection may spread from one patient to another due to the surgical equipment, thus requiring strict sterilization and disposal.

The pharmaceutical sector also promotes the adoption of infection control methods to reduce the contamination of drug powder produced while manufacturing the drugs. The rising adoption of technological advancements in infection control methods is anticipated to fuel the growth rate of the European market. Furthermore, growing R&D activities to develop advanced and effective infection control products and solutions and the presence of local key players are accelerating the growth of the European infection control market.

On the other hand, side effects associated with disinfectants, such as irritation in the eye, skin rashes, and itching in the infection control methods, is a major obstacle to the market growth in Europe. Furthermore, lack of awareness among people of infection control advantages, lack of availability of infection control devices, and high cost of the devices used for infection control are further anticipated to inhibit the market’s growth rate in Europe.

This research report on the European infection control market has been segmented and sub-segmented into the following categories.

By Products and Services:

• Cleaning and Disinfection Products
• Sterilization Products and Services
• Endoscope Reprocessing Products
• Protective Equipment
• Others

The cleaning and disinfection products segment led the European infection control market in 2021, followed by the sterilization products and services segment and protection equipment segment.

By End-User:

• Hospitals and Clinics
• Medical Device Companies
• Pharmaceutical Companies
• Life Sciences Companies
• Food Industry
• Others

Based on the end-user, the hospitals and clinics segment had the major share of the European infection control market in 2021.

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European infection control market accounted for the second-largest share of the worldwide market in 2021. During the forecast period, the European market is expected to have promising occupancy in the global market owing to the increasing number of infection control products entering the market and growing awareness among people and healthcare providers regarding the importance of sterilization and being safe from infections. Europe was hit badly by the recent COVID-19 pandemic. Due to this, the adoption of infection control has increased dramatically and contributed to regional market growth. In addition, the rising number of awareness programs by the European governments and key market participants to spread awareness of infection control is expected to favor the European infection control market growth. The growing incidence of various infectious diseases also supports regional market growth. The people of Europe are now using various portable infection control devices to keep them safe and healthy from infections, which is expected to result in market growth in the coming years.

The German infection control market had a considerable share of the European market in 2021 and is expected to witness a notable CAGR during the foreseen years. The focus on infection control has grown significantly in recent years. As a result, people and hospitals are practicing several measures to protect themselves from infections. Also, the German government has given several guidelines to healthcare facilities, such as hospitals, clinics, and diagnostic centers, to keep people safe from infections. In addition, the increasing number of investments by the German government to develop advanced and effective infection control devices and solutions at affordable cost is accelerating the market growth in Germany.

The UK infection control market is expected to showcase the fastest CAGR in the European region during the forecast period. The rising incidence of hospital-acquired infections in the UK and the increasing number of infection control training centers are majorly propelling the UK infection control market. In addition, the growing patient population admitted to hospitals for treatments and the rising adoption of infection control by hospitals and clinics are expected to boost the market’s growth rate in the UK.

KEY MARKET PLAYERS:

Some of the prominent players participating in the European infection control market are Ecolab, Inc., Miele Group, Melag, Pal International, STERIS plc., Getinge AB, Cantel Medical Corporation, Advanced Sterilization Product, 3M Company, MMM Group, and Belimed AG.